Report Code : CVMI24071612 | Published Date : July 16, 2024
nan




Reasons To Buy

nan




Scope

nan

Key Players

  • Shire (Takeda Pharmaceutical Company)
  • CSL Behring
  • Pharming Group NV
  • Sanquin
Global Plasma Protease C1-inhibitor Market Report

Global Plasma Protease C1-inhibitor Market Report

    1. Global Plasma Protease C1-inhibitor Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Plasma Protease C1-inhibitor Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Plasma Protease C1-inhibitor Market Research Report - Preface
    1. 2.1 Global Plasma Protease C1-inhibitor Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type
      2. 2.1.2 By Product Type
      3. 2.1.3 By Dosage Form
      4. 2.1.4 By Administration Route
      5. 2.1.5 By Region
    3. Global Plasma Protease C1-inhibitor Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type, By Product Type, By Dosage Form, By Administration Route, By Country
    3. 3.3. Opportunities – By Type, By Product Type, By Dosage Form, By Administration Route, By Country
    4. 3.4. Trends – By Type, By Product Type, By Dosage Form, By Administration Route, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Plasma Protease C1-inhibitor Market Research Report – DROTs Impact Analysis
    4. Global Plasma Protease C1-inhibitor Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Plasma Protease C1-inhibitor Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Hereditary Angioedema (HAE)
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Acquired Angioedema (AAE)
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Plasma Protease C1-inhibitor Market, By Product Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Plasma-derived C1-inhibitor
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Recombinant C1-inhibitor
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Plasma Protease C1-inhibitor Market, By Dosage Form, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Injectable Solution
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Lyophilized Powder for Reconstitution
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Plasma Protease C1-inhibitor Market, By Administration Route, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 Intravenous (IV)
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Subcutaneous (SC).
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    9. Global Plasma Protease C1-inhibitor Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 North America
      1. 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 9.2 Europe
      1. 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 9.3 Asia-Pacific
      1. 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 9.4 Latin America
      1. 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 9.5 Middle East & Africa
      1. 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      6. 9.6 Global Plasma Protease C1-inhibitor Market - Opportunity Analysis Index, By Type, By Product Type, By Dosage Form, By Administration Route, and Region, 2024 - 2031
    10. North America Global Plasma Protease C1-inhibitor Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Hereditary Angioedema (HAE)
      2. 10.1.2 Acquired Angioedema (AAE)
      10.2 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Plasma-derived C1-inhibitor
      2. 10.2.2 Recombinant C1-inhibitor
      10.3 By Dosage Form Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Injectable Solution
      2. 10.3.2 Lyophilized Powder for Reconstitution
      10.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Intravenous (IV)
      2. 10.4.2 Subcutaneous (SC).
      10.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.5.1 United States
      2. 10.5.2 Canada
      10.6 North America Global Plasma Protease C1-inhibitor Market – Opportunity Analysis Index, By Type, By Product Type, By Dosage Form, By Administration Route, and Country, 2024 - 2031
      10.7 Regional Trends Analysis
      10.8 North America Global Plasma Protease C1-inhibitor Market Research Report - Company Profiles
      1. 10.8.1 Company 1 (United States)
      2. 10.8.2 Company 2 (Canada)
      3. 10.8.3 Company 3 (Canada)
    11. Europe Global Plasma Protease C1-inhibitor Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Hereditary Angioedema (HAE)
      2. 11.1.2 Acquired Angioedema (AAE)
      11.2 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Plasma-derived C1-inhibitor
      2. 11.2.2 Recombinant C1-inhibitor
      11.3 By Dosage Form Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Injectable Solution
      2. 11.3.2 Lyophilized Powder for Reconstitution
      11.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Intravenous (IV)
      2. 11.4.2 Subcutaneous (SC).
      11.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.5.1 Germany
      2. 11.5.2 United Kingdom
      3. 11.5.3 France
      4. 11.5.4 Spain
      5. 11.5.5 Italy
      6. 11.5.6 Russia
      7. 11.5.7 Netherlands
      8. 11.5.8 Poland
      9. 11.5.9 Rest of Europe
      11.6 Europe Global Plasma Protease C1-inhibitor Market – Opportunity Analysis Index, By Type, By Product Type, By Dosage Form, By Administration Route, and Country, 2024 - 2031
      11.7 Regional Trends Analysis
      11.8 Europe Global Plasma Protease C1-inhibitor Market Research Report - Company Profiles
      1. 11.8.1 Company 1 (Germany)
      2. 11.8.2 Company 2 (United Kingdom)
      3. 11.8.3 Company 3 (United Kingdom)
    12. Asia-Pacific Global Plasma Protease C1-inhibitor Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Hereditary Angioedema (HAE)
      2. 12.1.2 Acquired Angioedema (AAE)
      12.2 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Plasma-derived C1-inhibitor
      2. 12.2.2 Recombinant C1-inhibitor
      12.3 By Dosage Form Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Injectable Solution
      2. 12.3.2 Lyophilized Powder for Reconstitution
      12.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Intravenous (IV)
      2. 12.4.2 Subcutaneous (SC).
      12.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.5.1 China
      2. 12.5.2 Japan
      3. 12.5.3 India
      4. 12.5.4 South Korea
      5. 12.5.5 Australia & NZ
      6. 12.5.6 ASEAN
      7. 12.5.7 Rest of Asia-Pacific
      12.6 Asia-Pacific Global Plasma Protease C1-inhibitor Market – Opportunity Analysis Index, By Type, By Product Type, By Dosage Form, By Administration Route, and Country, 2024 - 2031
      12.7 Regional Trends Analysis
      12.8 Asia-Pacific Global Plasma Protease C1-inhibitor Market Research Report - Company Profiles
      1. 12.8.1 Company 1 (China)
      2. 12.8.2 Company 2 (Japan)
      3. 12.8.3 Company 3 (Japan)
    13. Latin America Global Plasma Protease C1-inhibitor Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Hereditary Angioedema (HAE)
      2. 13.1.2 Acquired Angioedema (AAE)
      13.2 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Plasma-derived C1-inhibitor
      2. 13.2.2 Recombinant C1-inhibitor
      13.3 By Dosage Form Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Injectable Solution
      2. 13.3.2 Lyophilized Powder for Reconstitution
      13.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Intravenous (IV)
      2. 13.4.2 Subcutaneous (SC).
      13.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.5.1 Brazil
      2. 13.5.2 Mexico
      3. 13.5.3 Argentina
      4. 13.5.4 Peru
      5. 13.5.5 Colombia
      6. 13.5.6 Rest of Latin America
      13.6 Latin America Global Plasma Protease C1-inhibitor Market – Opportunity Analysis Index, By Type, By Product Type, By Dosage Form, By Administration Route, and Country, 2024 - 2031
      13.7 Regional Trends Analysis
      13.8 Latin America Global Plasma Protease C1-inhibitor Market Research Report - Company Profiles
      1. 13.8.1 Company 1 (Brazil)
      2. 13.8.2 Company 2 (Mexico)
      3. 13.8.3 Company 3 (Mexico)
    14. Middle East & Africa Global Plasma Protease C1-inhibitor Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      14.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.1.1 Hereditary Angioedema (HAE)
      2. 14.1.2 Acquired Angioedema (AAE)
      14.2 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.2.1 Plasma-derived C1-inhibitor
      2. 14.2.2 Recombinant C1-inhibitor
      14.3 By Dosage Form Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.3.1 Injectable Solution
      2. 14.3.2 Lyophilized Powder for Reconstitution
      14.4 By Administration Route Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.4.1 Intravenous (IV)
      2. 14.4.2 Subcutaneous (SC).
      14.5 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 14.5.1 Saudi Arabia
      2. 14.5.2 UAE
      3. 14.5.3 South Africa
      4. 14.5.4 Egypt
      5. 14.5.5 Israel
      6. 14.5.6 Rest of Middle East and Africa
      14.6 Middle East & Africa Global Plasma Protease C1-inhibitor Market – Opportunity Analysis Index, By Type, By Product Type, By Dosage Form, By Administration Route, and Country, 2024 - 2031
      14.7 Regional Trends Analysis
      14.8 Middle East & Africa Global Plasma Protease C1-inhibitor Market Research Report - Company Profiles
      1. 14.8.1 Company 1 (Saudi Arabia)
      2. 14.8.2 Company 2 (UAE)
      3. 14.8.3 Company 3 (UAE)
    15. Competition Landscape
      15.1 Strategic Dashboard of Top Market Players
      15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 15.2.1 Shire (Takeda Pharmaceutical Company)
      2. 15.2.2 CSL Behring
      3. 15.2.3 Pharming Group NV
      4. 15.2.4 Sanquin
    16. Data Collection Method and Research Approach
    17. Principal Presumptions and Acronyms